Literature DB >> 3390695

Gastrin-releasing peptide (GRP) immunoreactivity in the rat retina: a radioimmunoassay, immunohistochemical and chromatographic study.

J M McKillop1, W L Foy, C F Johnston, C Shaw, R F Murphy, K D Buchanan.   

Abstract

Using radioimmunoassay, reverse phase high pressure liquid chromatography (rp HPLC) and immunohistochemistry, we have identified gastrin releasing peptide-immunoreactivity (GRP-IR) in the rat retina. The concentration of GRP-IR in retinal extracts was 7.4 +/- 0.6 ng/g wet wt. (mean +/- S.E.M. n = 15). There was no significant difference between the levels of immunoreactivity in 12-h light and 12-h dark adapted retinae. rp HPLC analysis of retinal extracts demonstrated that two main immunoreactive components were present which corresponded in retention time to GRP10 (neuromedin C) and GRP14 (GRP14-27). A small amount of material also co-eluted with GRP27. Using immunohistochemistry, the immunoreactivity has been localised in the inner retinal layers. Immunoreactive somata were present in the proximal inner nuclear layer and in the ganglion cell layer. Fibre staining was present in laminae 2 and 4 of the inner plexiform layer. Somatal staining was increased by pretreatment of retinae with vincristine while the laminar staining was markedly reduced. These results demonstrate the existence of GRP-like peptides in the rat retina which has not previously been reported.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3390695     DOI: 10.1016/0006-8993(88)91125-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  2 in total

1.  Gastrin-releasing peptide in human nasal mucosa.

Authors:  J N Baraniuk; J D Lundgren; J Goff; D Peden; M Merida; J Shelhamer; M Kaliner
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

2.  Gastrin-releasing peptide phase-shifts suprachiasmatic nuclei neuronal rhythms in vitro.

Authors:  A J McArthur; A N Coogan; S Ajpru; D Sugden; S M Biello; H D Piggins
Journal:  J Neurosci       Date:  2000-07-15       Impact factor: 6.167

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.